Ascendis Pharma A/S announced new pooled data demonstrating early, sustained, and clinically meaningful improvements in kidney function in adults with hypoparathyroidism treated with TransCon PTH ...

A/S (Nasdaq: ASND) today announced new data demonstrating early, sustained, and clinically meaningful improvements in kidney function in adults with hypoparathyroidism treated with TransCon® PTH ...

Pathalys Pharma, Inc., a private, US-based biopharmaceutical company committed to supporting the unique needs of patients with chronic kidney disease (CKD), today presented data demonstrating the ...

The same was found when parathyroid hormone was injected into the Achilles tendon of rats, which created a cartilaginous matrix within the tendon tissue. The researchers grafted the Achilles tendons ...

Researchers led by Prof. Yang Fan from the Shenzhen Institute of Advanced Technology (SIAT) of the Chinese Academy of Sciences and their collaborators have proposed a new approach to control ...

Please provide your email address to receive an email when new articles are posted on . The researchers conducted a prospective, population-based, longitudinal cohort study of women from the Malmö ...

Parathyroid hormone (PTH) is an 84 amino acid that plays a key role in phosphocalcic metabolism. Its measurement is essential to diagnose and treat primary hyperparathyroidism and to evaluate chronic ...